Wird geladen...
Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms
Glucagon-like peptide 1 receptor agonists and dipeptidyl-peptidase 4 inhibitors are medications used for managing diabetes, mimicking the metabolic effects of incretin hormones. Recent evidence suggests that these medications have antioxidative potentials in the diabetic milieu. The pathophysiology...
Gespeichert in:
| Veröffentlicht in: | Oxid Med Cell Longev |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Hindawi
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8099522/ https://ncbi.nlm.nih.gov/pubmed/34007411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/9959320 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|